Number two, Walgreens Boots Alliance (-8%) The pharmacy giant Walgreens Boots Alliance (NASDAQ: WBA) is no stranger to this list; in fact, it's not surprising given the company's history of underperformance on the Dow.
Earlier this month, Walgreens revealed its fiscal first-quarter profits, and the results were better than expected. A combination of "challenging retail market trends" and a higher tax rate led to a precipitous 43% year-over-year decline in adjusted profits per share, which came to $0.66.
The company's 48% dividend cut, to $0.25 per share, was the true culprit behind the stock's precipitous decline. In a recent move to reduce expenses, save money, and boost profits, the firm has decided to decrease its dividend. In a statement, management stated, "We are evaluating all strategic options to drive sustainable long-term shareholder value, focusing on swift actions to right-size costs and increase cash flow
Still, Walgreens doesn't seem like a good choice, what with the company's persistent issues and the precipitous drop in dividend yield—the main argument against owning the stock.
Thirdly, Intel (down 5.2%). Intel (NASDAQ: INTC) has not been the subject of any significant news releases, in contrast to the other two equities mentioned here. As part of a larger market sell-off in response to concerns that interest rates may stay rising for longer than anticipated, the stock price dropped significantly in the first trading session of the year.
Ever since, the stock has been relatively unchanged, but it hasn't kept pace with Nvidia, the semiconductor industry leader in AI processors.
Nvidia has also unveiled a new lineup of artificial intelligence PC processors meant to rival Intel's offerings. This development may force Intel to take action, either offensively or defensively, in the PC chip market. Investors' expectations regarding Intel were different from that story. Since it was anticipated to compete with Nvidia in artificial intelligence processors, shares rose last year.
Due to a general downturn in sales of PC chips, Intel's main business providing PCs is still poor, and the firm will require a catalyst to boost its business in 2024. The company's stock price may fall if its AI initiative is unsuccessful.